Vaccine Stocks Drop on Worries About an RFK Jr. Role
It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants” in his administration. In a video posted last week, Kennedy said that Trump had “promised” him control of several health-focused governmental offices, including Health and Human Services.